Lumen Bioscience to convert former Wallingford bakery into algae plant, quintupling spirulina output after $16M Series B
Seattle biotech Lumen Bioscience will convert a former Wallingford bakery into an algae-based manufacturing facility to roughly quintuple spirulina production from about 3 kg per week, following a $16M Series B and several new partnerships and grants.
No comments yet.